Why is Brawn Biotech falling/rising?

As of 19-Nov, Brawn Biotech Ltd's stock price is currently at Rs 22.05, reflecting a decrease of Rs 1.1 or 4.75%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 9.45% during this period. Today's trading opened with a loss of 3.89%, and the stock reached an intraday low of Rs 22.05. Additionally, the stock has traded in a narrow range of Rs 0.2 and has shown a significant drop in investor participation, with delivery volume decreasing by 82.96% compared to the 5-day average. Despite some positive returns over the past week and month, the year-to-date and yearly returns are notably lower than the benchmark Sensex, indicating a challenging environment for the stock.
Broader Market Context: In the short term, Brawn Biotech's performance has been relatively weak compared to the Sensex, which has gained 0.85% over the past week while the stock itself has increased by 4.70%. However, the stock's recent decline contrasts sharply with its longer-term performance, where it has shown a 10.25% increase over the past month. The broader market context suggests that while the stock has had some positive movements, the current downturn may be influenced by a combination of reduced investor interest and overall market conditions that are not favoring the stock at this time.